These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
580 related items for PubMed ID: 34338398
1. Local anesthetic bupivacaine inhibits proliferation and metastasis of hepatocellular carcinoma cells via suppressing PI3K/Akt and MAPK signaling. Wang L, Guo W, Guan H, Yan N, Cai X, Zhu L. J Biochem Mol Toxicol; 2021 Oct; 35(10):e22871. PubMed ID: 34338398 [Abstract] [Full Text] [Related]
2. Ropivacaine suppresses tumor biological characteristics of human hepatocellular carcinoma via inhibiting IGF-1R/PI3K/AKT/mTOR signaling axis. Zhang R, Lian Y, Xie K, Cai Y, Pan Y, Zhu Y. Bioengineered; 2021 Dec; 12(2):9162-9173. PubMed ID: 34696683 [Abstract] [Full Text] [Related]
3. Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways. Yang L, Hu Y, Zhou G, Chen Q, Song Z. Biosci Rep; 2020 Jul 31; 40(7):. PubMed ID: 32677672 [Abstract] [Full Text] [Related]
7. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway. Xie L, Li M, Liu D, Wang X, Wang P, Dai H, Yang W, Liu W, Hu X, Zhao M. Molecules; 2019 Jan 22; 24(3):. PubMed ID: 30678274 [Abstract] [Full Text] [Related]
8. Curzerene suppresses hepatocellular carcinoma progression through the PI3K/AKT/MTOR pathway. Luo Y, Wang Z, Jiang J, Wu S, Zhai Y. Rev Invest Clin; 2024 Jul 24; 76(4):173-184. PubMed ID: 39047236 [Abstract] [Full Text] [Related]
9. Erinacine Facilitates the Opening of the Mitochondrial Permeability Transition Pore Through the Inhibition of the PI3K/ Akt/GSK-3β Signaling Pathway in Human Hepatocellular Carcinoma. Zhou LJ, Mo YB, Bu X, Wang JJ, Bai J, Zhang JW, Cheng AB, Ma JH, Wang YW, Xie YX. Cell Physiol Biochem; 2018 Jul 24; 50(3):851-867. PubMed ID: 30355923 [Abstract] [Full Text] [Related]
10. Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2/STAT3 and PI3K/Akt pathways in an EphB4-dependent manner. Zhu M, Shi X, Gong Z, Su Q, Yu R, Wang B, Yang T, Dai B, Zhan Y, Zhang D, Zhang Y. Pharmacol Res; 2020 Aug 24; 158():104868. PubMed ID: 32407961 [Abstract] [Full Text] [Related]
13. Lappaconitine Sulfate Inhibits Proliferation and Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells through the Reactive Oxygen Species-Dependent Mitochondrial Pathway. Zhang X, Ma J, Song N, Guo Y, Hui L, Sang C. Pharmacology; 2020 Aug 24; 105(11-12):705-714. PubMed ID: 32062649 [Abstract] [Full Text] [Related]
14. Involvement of PI3K/Akt pathway in the inhibition of hepatocarcinoma cell invasion and metastasis induced by SASH1 through downregulating Shh-Gli1 signaling. Sun C, Zhang Z, He P, Zhou Y, Xie X. Int J Biochem Cell Biol; 2017 Aug 24; 89():95-100. PubMed ID: 28600143 [Abstract] [Full Text] [Related]
17. The epigallocatechin gallate derivative Y6 inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK/ERK1/2 and PI3K/AKT/ HIF-1α/VEGF dependent pathways. Liao ZH, Zhu HQ, Chen YY, Chen RL, Fu LX, Li L, Zhou H, Zhou JL, Liang G. J Ethnopharmacol; 2020 Sep 15; 259():112852. PubMed ID: 32278759 [Abstract] [Full Text] [Related]
18. Da-Chai-Hu-Tang Formula inhibits the progression and metastasis in HepG2 cells through modulation of the PI3K/AKT/STAT3-induced cell cycle arrest and apoptosis. Duan ZW, Liu Y, Zhang PP, Hu JY, Mo ZX, Liu WQ, Ma X, Zhou XH, Wang XH, Hu XH, Wei SL. J Ethnopharmacol; 2024 Sep 15; 331():118293. PubMed ID: 38705430 [Abstract] [Full Text] [Related]
19. Piezoeletric cold atmospheric plasma induces apoptosis and autophagy in human hepatocellular carcinoma cells through blocking glycolysis and AKT/mTOR/HIF-1α pathway. Wang Y, Mang X, Li D, Chen Y, Cai Z, Tan F. Free Radic Biol Med; 2023 Nov 01; 208():134-152. PubMed ID: 37543168 [Abstract] [Full Text] [Related]
20. Puerarin 6″-O-xyloside suppressed HCC via regulating proliferation, stemness, and apoptosis with inhibited PI3K/AKT/mTOR. Li L, Liu JD, Gao GD, Zhang K, Song YW, Li HB. Cancer Med; 2020 Sep 01; 9(17):6399-6410. PubMed ID: 32691991 [Abstract] [Full Text] [Related] Page: [Next] [New Search]